1-5 of 5
Gudrun Russ
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Validation of Recent Response Criteria (ELN-22, IWG-23 and PB-CR) in 1634 MDS/CMML/AML Patients Treated with HMA or HMA-Ven Using CPH Models and a CPH Deep Neural Network - Can or Should Response Criteria be Harmonized for Similarly Treated Patients?

Lisa Pleyer, Marc Vaisband, Patrick Klammer, Manuel Drost, Hubert Angermann, Felix Keil, Verena Petzer, Sonja Heibl, Jennifer Moritz, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Angelika Pichler, Bernd L. Hartmann, Gregor Aschauer, Clemens Schmitt, Sonia Vallet, Szilvia Boros, Petra Pichler, Andrea Hammerl-Steiner, Felix Renneberg, Dilyan Majjiga, Gudrun Russ, Alexander Egle, Michael Leisch, Thomas Melchardt, Nadja Zaborsky, Viktoria Faber, Jan Philipp Bewersdorf, Amer M. Zeidan, Jan Hasenauer, Richard Greil
Journal: Blood
Blood (2024) 144 (Supplement 1): 7511.
https://doi.org/10.1182/blood-2024-208073
Published: 2024
Journal Articles

Condensed Versus Standard Schedule of High-Dose Cytarabine Consolidation Therapy with Pegfilgrastim Growth Factor Support in Acute Myeloid Leukemia

Sonia Jaramillo, MD, Axel Benner, Jurgen Krauter, Hans Martin, MD, Thomas Kindler, MD, Martin Bentz, MD, Helmut R. Salih, MD, Gerhard Held, MD, Caus-Henning Köhne, MD, Katharina Götze, Michael Lübbert, MD, Andrea Kündgen, MD, Peter Brossart, MD, Mohammad Amen Wattad, MD, Hans-Juergen Salwender, MD, Bernd Hertenstein, MD, David Nachbaur, MD, Gerald Wulf, MD, Heinz A. Horst, MD PhD, Heinz Kirchen, MD, Walter Fiedler, MD, Aruna Raghavachar, MD, Gudrun Russ, MD, Stephan Kremers, Elisabeth Koller, MD, Volker Runde, MD, Gerhard Heil, Daniela Weber, Brigitte Schlegelberger, Prof, MD, Konstanze Döhner, MD, Arnold Ganser, MD, Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2016) 128 (22): 337.
https://doi.org/10.1182/blood.V128.22.337.337
Published: 2016
Journal Articles

Minimal Residual Disease (MRD) and T/NK Cell Dynamics during Fludarabine, Cyclophosphamide Plus Rituximab (FCR) Followed by Fludarabine Plus Rituximab (FR) and Remission Maintenance Therapy with Rituximab in Previously Untreated B-Chronic Lymphocytic Leukemia (B-CLL): Riskfactor Stratification in the Chairos Study

Alexander Egle, MD, Lukas Weiss, Franz Gassner, Gudrun Russ, Lisa Pleyer, Eberhard Gunsilius, MD, Inge Tinhofer, Josef Thaler, MD, Andreas L. Petzer, MD, Richard Greil
Journal: Blood
Blood (2008) 112 (11): 3175.
https://doi.org/10.1182/blood.V112.11.3175.3175
Published: 2008
Journal Articles

Role of Etoposide in Combination with All- Trans Retinoic Acid in the Treatment of Elderly Patients with Acute Myeloid Leukemia and NPM1 Mutation

Marie-Luise Hütter, Konstanze Döhner, Ingo G.H. Schmidt-Wolf, Francisco Del Valle, Björn Heydrich, Wolfgang Heit, Walter Fiedler, Michael Pfreundschuh, MD, PhD, Gudrun Russ, Martin Bentz, Aruna Raghavachar, Detlef Haase, MD, PhD, Wolfram Brugger, MD, Katharina Götze, Silja Groner, Hartmut Döhner, Richard Schlenk
Journal: Blood
Blood (2008) 112 (11): 559.
https://doi.org/10.1182/blood.V112.11.559.559
Published: 2008
Journal Articles

Planned First Efficacy and Safety Analysis of De-Intensified Induction with Fludarabine, Cyclophosphamide Plus Rituximab (FCR) Followed by Fludarabine Plus Rituximab (FR) and Remission Maintenance Therapy with Rituximab in Previously Untreated B-Chronic Lymphocytic Leukemia (B-CLL): The Chairos Study.

Alexander Egle, MD, Lukas Weiss, MD, Gudrun Russ, MD, Ralf Thoedtmann, MD, Lisa Pleyer, MD, Guenther Gastl, MD, Josef Thaler, MD, Andreas Petzer, MD, Inge Tinhofer, PhD, Richard Greil, MD
Journal: Blood
Blood (2007) 110 (11): 2045.
https://doi.org/10.1182/blood.V110.11.2045.2045
Published: 2007